Donate

Blog

T1International Statement on Executive Orders

T1International Statement on Executive Orders

On Friday afternoon, President Trump released four executive orders intended to lower drug prices, including two targeted directly at lowering the cost of insulin for patients who rely on it. Despite his assertion that these orders are intended to “completely restructure the prescription drug market,” these orders will not do anything to fix the underlying cause of the insulin crisis in America. Patients will still need to wait months for the rulemaking process to run its course, and likely even longer after that if these orders end up in court. While T1International USA is glad that the administration has stated that making insulin more affordable is a priority, these orders miss the mark. We don’t need incremental bureaucratic steps as an election approaches - we need transformative change that will make our medicine more affordable now. Read more

Fighting for LGBTQ+ Justice and #insulin4all

Fighting for LGBTQ+ Justice and #insulin4all

Delaying care due to these fears as a queer or trans person is not uncommon in any medical setting, however if you delay care living with diabetes, it can lead to life-threatening complications or even worse. It’s imperative that LGBTQ+ people living with diabetes and other chronic illnesses have the security, affirmation and resources to access the care they need. Read more

T1International Statement on Pharma’s Attempt to Block Minnesota’s Insulin Bill

T1International Statement on Pharma’s Attempt to Block Minnesota’s Insulin Bill

T1International is outraged, though not surprised, to see pharmaceutical companies once again put profit over human lives. On Tuesday, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against the state of Minnesota to challenge the Alec Smith Insulin Affordability Act. Read more

An Insulin Resolution is Necessary for Lebanon and the World

An Insulin Resolution is Necessary for Lebanon and the World

Lebanon’s recent financial crisis has caused a dollar shortage that, since September, has restricted the ability of medical supply importers to import vital medical supplies. First it started with masks, gloves, and other protective gear, as well as ventilators and spare parts, and now even essential diabetes supplies are sometimes unavailable. Read more

T1International Statement on World Health Assembly Insulin Resolution Meeting

T1International Statement on World Health Assembly Insulin Resolution Meeting

We were proud that Cyrine Farhat of Lebanon represented T1International, the #insulin4all movement and people living with type 1 diabetes as one of six speakers at a collaborative virtual event about a WHA Resolution on Access to Insulin. Read more

My Black Diabetic Life Matters

My Black Diabetic Life Matters

When I left the hospital I remember wondering, “Why did my mom have to beg those people to do their job when I was visibly sick?” A few years later after I had dealt with numerous visits, checkups, and insurance calls, I became aware of the medical side of racism. Read more

Utahns Welcome Passage of Insulin Access Amendments

Utahns Welcome Passage of Insulin Access Amendments

After many emotional months of fighting hard for accessible and affordable insulin legislation, Utah won a victory March 30, 2020 when House Bill 207, known as the Insulin Access Amendments, was signed into law by Governor Gary Herbert. This victory was thanks in part to the strong advocacy of thousands of Utahns and to Representative Norman Thurston’s dedicated leadership on drafting lifesaving legislation. This legislation passed with strong bipartisan support through the House with a 69-3 vote and passed unanimously in the Senate. Read more

Launch of U.S. State Legislative Guide for Insulin for All

Launch of U.S. State Legislative Guide for Insulin for All

T1International is pleased to introduce a new advocacy resource, the U.S. Legislative Guide for insulin for all: How States Can Make Medicines Affordable. The resource, developed in partnership with Public Citizen, outlines a variety of legislation that could help to make insulin more accessible and affordable. Read more

How Shareholders Benefit from Insulin Price Increases

How Shareholders Benefit from Insulin Price Increases

In March of this year, researchers at the University of Pittsburgh provided evidence that the net price of insulin medicines in the United States had also soared – by 51% between 2008-2017. This indicates that while other intermediaries had benefited from list price increases, the manufacturers had too. This may seem obvious, but having data to prove it is important. Read more

Advocates Celebrate Passage of Alec Smith Bill in Minnesota

Advocates Celebrate Passage of Alec Smith Bill in Minnesota

After months of diligent advocacy, partisan gridlock, and intense negotiations, the Alec Smith Emergency Insulin Bill was signed into law today in Minnesota. Alec’s Bill is named for 26-year-old Alec Smith, who passed away after rationing his insulin in 2017. The legislation, which is the first of its kind in the nation, establishes a program for patients with diabetes to purchase the insulin they need at an affordable price. To get to this moment, advocates in Minnesota endured a tough - and long - fight. Read more